New Jersey Senate Bill S1845

New Jersey 2022-2023 Regular Session

• Introduced: 2/28/22
• Refer: 2/28/22

Caption

Requires DOC and county correctional facilities to provide certain inmates with medication-assisted treatment.

Impact

The enactment of S1845 is expected to significantly impact correctional health care by establishing a structured approach to manage and treat substance use disorders within the prison population. It aims to enhance the quality of health care available to inmates, thereby potentially reducing recidivism rates associated with substance dependency. The requirement for comprehensive evaluations and the availability of MAT are crucial steps toward reintegrating inmates into society healthier and more equipped to handle their conditions.

Summary

Senate Bill S1845 in New Jersey is a legislative measure aimed at providing medication-assisted treatment (MAT) for inmates whose initial evaluations indicate they are struggling with substance use disorders. This bill mandates that both state and county correctional facilities evaluate incoming inmates to determine their need for MAT. If deemed necessary, inmates can voluntarily opt to participate in the treatment, which combines medications approved by the FDA with counseling and behavioral therapies.

Contention

While supporters of S1845 argue that it represents a progressive move toward treating addiction as a health issue rather than solely a criminal one, concerns exist regarding the implementation of such programs in a correctional setting. Critics may argue about the adequacy of resources required to deliver these treatments effectively within prisons, along with potential issues regarding consent and the voluntary nature of the treatment amidst a coercive environment. These debates highlight the tension between rehabilitation and punishment within the criminal justice system.